Sign in

Trial result ·

Short-Term Anticoagulant Therapy and Subclinical Leaflet Thickening in Transcatheter Aortic Valves: The NOTION-4 Trial.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

People in this trial had a new aortic valve put in through a tube. None of them needed a blood thinner taken by mouth. By chance, each person was put into one of the groups. One group took a single antiplatelet drug, called SAPT, for life. The other took a DOAC blood thinner for 3 months, then SAPT for life. Heart scans checked for a thickening of the valve flaps, called HALT.

What they found

Of 352 people, 5 failed screening or took back their consent. That left 176 on SAPT and 171 on the DOAC plan. At 3 months, HALT was less common in the DOAC group. At 1 year, HALT rates were close in both groups. The gap at 1 year was not clear enough to rule out chance. Death, stroke, or major bleeding by 12 months was more common with DOAC.

What it means for patients

The authors say 3 months of DOAC cut HALT at 3 months. But this effect faded by 9 months after the DOAC was stopped. The DOAC group also had more deaths, strokes, or major bleeds taken together.

Why it is not certain yet

The main test was HALT at 12 months, and it showed no clear gap. The abstract says HALT only might be linked to clot problems. At 1 year, only people with a scan were counted for HALT. The abstract does not say how many people had no scan. The trial only took people who did not need a blood thinner by mouth.

The registered trial

The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.

Source

Short-Term Anticoagulant Therapy and Subclinical Leaflet Thickening in Transcatheter Aortic Valves: The NOTION-4 Trial.

PubMed · PMID 42669071

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Aortic stenosis publications